tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
US Market

Inhibikase Therapeutics (IKT) Technical Analysis

Compare
172 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Inhibikase Therapeutics is a Sell.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 1.58, while Inhibikase Therapeutics’s (IKT) share price is $1.65, making it a Buy.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 1.57, while Inhibikase Therapeutics’s (IKT) share price is $1.65, making it a Buy.

Inhibikase Therapeutics (IKT) Pivot Points

Dec 27, 2025, 02:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.43
1.50
1.54
1.61
1.65
1.72
1.76
Fibonacci
1.50
1.54
1.56
1.61
1.65
1.67
1.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inhibikase Therapeutics (IKT) Moving Averages

Dec 27, 2025, 02:01 AM
Period
Simple
Exponential
MA5
1.66Sell
1.64Buy
MA10
1.62Buy
1.61Buy
MA20
1.55Buy
1.58Buy
MA50
1.55Buy
1.57Buy
MA100
1.61Buy
1.64Buy
MA200
1.79Sell
1.86Sell
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.61, while Inhibikase Therapeutics’s (IKT) share price is $1.65, making it a Buy.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.64, while Inhibikase Therapeutics’s (IKT) share price is $1.65, making it a Buy.
Inhibikase Therapeutics’s (IKT) stock price is $1.65 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.55, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.65 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.61, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.65 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.79, creating a Sell signal.

Inhibikase Therapeutics (IKT) Technical Indicators

Dec 27, 2025, 02:01 AM
Name
Value
Implied Action
RSI (14)
56.32
Neutral
STOCH (9,6)
49.40
Neutral
STOCHRSI (14)
56.80
Neutral
MACD (12,26)
0.03
Sell
ADX (14)
19.21
Buy
Williams %R
-39.56
Buy
CCI (14)
88.73
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
48.59
Neutral
ROC
9.27
Buy
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 56.32, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 19.21, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is 88.73, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is 9.27, creating a Buy signal.

FAQ

Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Buy.
    What is IKT’s RSI (14)?
    IKT’s RSI (14) is 56.32, which suggests IKT is a Neutral.
      What is IKT’s MACD?
      IKT’s MACD is 0.03, which suggests IKT is a Sell.
        What is IKT’s 5-day moving average?
        IKT’s 5-day moving average is 1.66, which suggests IKT is a Sell.
          What is IKT’s 20-day moving average?
          IKT 20-day moving average is 1.55, which suggests IKT is a Buy.
            What is IKT’s 50-day moving average?
            IKT’s 50-day moving average is 1.55, which suggests IKT is a Buy.
              What is IKT’s 200-day moving average?
              IKT’s 200-day moving average is 1.79, which suggests IKT is a Sell.
                What is IKT’s Williams % R (14)?
                IKT’s Williams % R (14) is -39.56, which suggests IKT is a Buy.
                  What is IKT’s CCI (14)?
                  IKT’s CCI (14) is 88.73, which suggests IKT is a Neutral.